X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.340
-0.030 (-0.89%)
At close: May 12, 2025, 4:00 PM
3.500
+0.160 (4.79%)
After-hours: May 12, 2025, 7:44 PM EDT
X4 Pharmaceuticals Revenue
X4 Pharmaceuticals had revenue of $28.81M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $31.36M. In the year 2024, X4 Pharmaceuticals had annual revenue of $2.56M.
Revenue (ttm)
$31.36M
Revenue Growth
n/a
P/S Ratio
0.72
Revenue / Employee
$219,329
Employees
143
Market Cap
19.33M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
XFOR News
- 11 days ago - X4 Pharmaceuticals, Inc. (XFOR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 14 days ago - Top 3 Health Care Stocks That May Rocket Higher In April - Benzinga
- 18 days ago - X4 Pharmaceuticals to Report First-Quarter 2025 Financial Results and Host Conference Call and Webcast on May 1, 2025 - GlobeNewsWire
- 18 days ago - X4 Pharmaceuticals Announces Reverse Stock Split - GlobeNewsWire
- 19 days ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals, Inc. (XFOR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire